Comments
Novartis gets EU nod for kidney tumor drug Votubia
05.11.2012. | ZURICH (Reuters) - Novartis said on Monday its drug Votubia had received approval from the European Commission for treating non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC)....
